Realizing the promise of apoptosis-based therapies: separating the living from the clinically undead.
Tilly
J L
JL
Kolesnick
R N
RN
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D061945:Caspase Inhibitors; D005260:Female; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D009369:Neoplasms / Q000188:drug therapy*; D010053:Ovary / Q000187:drug effects / Q000473:pathology; D011506:Proteins / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D061945:Caspase Inhibitors; D051034:Inhibitor of Apoptosis Proteins; D011506:Proteins